Evidence map›Paper›PMID 40723317›Full record

ReviewBiology2025

Role and Mechanisms of Angiogenesis in Tumours.

Aleksandra Sobczyńska-Rak, Beata Żylińska, Beata Nowicka, Eryk Rak, Tomasz Rzepka

Abstract readReview
In one paragraph

Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Inhibition of VEGFJournal of chemical information and modeling · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aleksandra Sobczyńska-RakDepartment and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, 20-612 Lublin, Poland.
Beata ŻylińskaDepartment and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, 20-612 Lublin, Poland.ORCID 0000-0001-9045-7992
Beata NowickaDepartment and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, 20-612 Lublin, Poland.ORCID 0000-0003-1240-323X
Eryk RakMedical Faculty-Student, Medical University of Lublin, 20-059 Lublin, Poland.
Tomasz RzepkaVeterinary Clinic "PUMA", 27-400 Ostrowiec Świętokrzyski, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article presents the accurate and current state of knowledge regarding the process of angiogenesis in neoplastic cells and its importance for tumour development. It provides a detailed review of the different types of angiogenesis with a brief discussion of individual angiogenic factors. Pathological angiogenesis in tumour tissues and the production of angiogenic factors have been recognised as key features responsible for cancerous development and distant metastasis formation since 1971. A phenomenon known as an angiogenic switch allows neoplasm to transform from an avascular to a vascular phase. The emerging new network of blood vessels allows cancer cells to efficiently exchange gases, provide nutrients and eliminate metabolic waste products. The main factors stimulating the angiogenesis process are VEGF, FGF, EGF, PDGF, and TGF-β1. To date, the most specific, strongest and most widely studied factor is VEGF. It is regarded as the main mitogen for vascular endothelial cells, stimulating their proliferation, and it is therefore referred to as a survival factor for cancer cells. Several mechanisms of new blood-vessel formation in cancerous tissue have also been identified. The three dominant processes include vascular sprouting, intussusceptive angiogenesis and vessel co-option. Angiogenesis in cancer tissues remains a subject of numerous scientific studies. A thorough understanding of the mechanism of oncogenesis and tumour expansion appears to be the starting point for future research aimed at finding effective anti-cancer therapy.

Indexed as

angiogenesisintussusceptive angiogenesistumourvascular sproutingvasculogenic mimicryVEGF

Identifiers

PMID40723317
PMCPMC12293050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.